Takeda Can't Decertify Amitiza Class After $885M Jury Loss
By Matthew Perlman · September 15, 2026, 6:33 PM EDT
A Massachusetts federal court refused Takeda's request to decertify a class of Amitiza buyers, after a jury awarded groups of purchasers a total of $885 million for claims that the drugmaker...
To view the full article, register now.